Lisaftoclax
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Lisaftoclax, covering 2024-05-29 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia [Phase 1]